No Picture
News

Gossamer Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, toda… […]

No Picture
News

China vows to continue speeding up drug approvals, expand tax cuts; Sorrento/Yuhan JV receives $40M financing

? In the latest move to spur introduction of new medicines, China has announced it will reduce the value-add tax on 21 rare disease drugs the same way it offered tax breaks to imported cancer drugs in April 2018. While good news to all drugmakers, the … […]

No Picture
News

Epic Sciences to Present at ASCO-GU 2019 New Data Demonstrating Utility of Liquid Biopsy to Optimize Drug Development

SAN DIEGO, Feb. 12, 2019 /PRNewswire/ — Epic Sciences, Inc. (Epic) announced today the presentation of four posters at the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO-GU), held in San Francisco on February 14-1… […]

No Picture
News

Southern California Philanthropists Richard and Melanie Lundquist Make $70 Million Unrestricted Gift to LA BioMed, Will Be Renamed Lundquist Institute

Funds will go toward recruiting top researchers and improving facilities in the South Bay region of LA County – one of the nation’s top ten biotech clusters

LOS ANGELES, Feb. 11, 2019 /PRNewswire/ — Southern California philanthropists Melanie and Ri… […]